Cargando…

Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

We have studied the effects of add-on spironolactone treatment (100 mg/day) in 11 patients with idiopathic membranous nephropathy (IMN) and >3 gm proteinuria/day despite angiotensin converting enzyme (ACE) inhibitor therapy titrated to a systolic/diastolic blood pressure <120/80 mmHg. Blood pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cravedi, Paolo, Brusegan, Varusca, Ruggenenti, Piero, Campbell, Ruth, Remuzzi, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991017/ https://www.ncbi.nlm.nih.gov/pubmed/27713239 http://dx.doi.org/10.3390/ph3010001

Ejemplares similares

Full-dose NSAIDs at the first sign of respiratory infection? – Authors’ reply
por: Ruggenenti, Piero, et al.
Publicado: (2022)

Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome
por: Perna, Annalisa, et al.
Publicado: (2022)

Functional Magnetic Resonance Imaging Versus Kidney Biopsy to Assess Response to Therapy in Nephrotic Syndrome: A Case Report
por: Caroli, Anna, et al.
Publicado: (2020)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome
por: Chen, Tianxin, et al.
Publicado: (2021)

Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomes
por: Ruggenenti, Piero, et al.
Publicado: (2021)

Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Perioperative Minimal Induction Therapy: A Further Step toward More Effective Immunosuppression in Transplantation
por: Gennarini, Alessia, et al.
Publicado: (2012)

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
por: Srivastava, Anand, et al.
Publicado: (2016)

Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
por: Dong, Dan, et al.
Publicado: (2019)

Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy
por: Cui, Hailan, et al.
Publicado: (2021)

Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination
por: Sharma, Sanjib Kumar, et al.
Publicado: (2007)

Extracorporeal Therapy for Idiopathic Nephrotic Syndrome
por: Au, Eric, et al.
Publicado: (2021)

Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT
por: De Cosmo, Salvatore, et al.
Publicado: (2009)

Nephrotic Syndrome and Idiopathic Membranous Nephropathy Associated with Autosomal-Dominant Polycystic Kidney Disease
por: Peces, Ramón, et al.
Publicado: (2011)

Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
por: Ruggenenti, Piero, et al.
Publicado: (2008)

Immunosuppressive Treatment for Nephrotic Idiopathic Membranous Nephropathy: A Meta-Analysis Based on Chinese Adults
por: Xie, Guoqiang, et al.
Publicado: (2012)

The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy
por: Liang, Qian, et al.
Publicado: (2017)

Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial
por: Ruggenenti, Piero, et al.
Publicado: (2010)

Electron-Dense Deposition Patterns and the Outcomes of Nephrotic Idiopathic Membranous Nephropathy Treated with Tacrolimus in Chinese Adults
por: Xiang, Xin, et al.
Publicado: (2021)

Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
por: Lee, Mi Young, et al.
Publicado: (2011)

Idiopathic hirsutism: Is it really idiopathic or is it misnomer?
por: Unluhizarci, Kursad, et al.
Publicado: (2023)

Non-lupus full-house nephropathy—immune dysregulation as a rare cause of pediatric nephrotic syndrome: Questions
por: Horváth, Orsolya, et al.
Publicado: (2021)

Non-lupus full-house nephropathy—immune dysregulation as a rare cause of pediatric nephrotic syndrome: Answers
por: Horváth, Orsolya, et al.
Publicado: (2021)

A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome
por: Vivarelli, Marina, et al.
Publicado: (2023)

Idiopathic or iatrogenic membranous glomerulonephritis? A case of spironolactone-induced membranous glomerulonephritis
por: Inaba, Akimichi, et al.
Publicado: (2011)

Chinese medicinal herbs for idiopathic membranous nephropathy in adults with nephrotic syndrome: A systematic review of effectiveness and safety
por: Liu, Meifang, et al.
Publicado: (2021)

Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?
por: Roubille, François, et al.
Publicado: (2022)

Idiopathic splanchnic vein thrombosis: is it really idiopathic?
por: Barosi, Giovanni
Publicado: (2022)

ACE polymorphism and diabetic nephropathy
por: Wiwanitkit, V.
Publicado: (2010)

Ponticelli regimen in idiopathic nephrotic syndrome
por: Das, U., et al.
Publicado: (2009)

Pathogens in Vasculitis: Is It Really Idiopathic?
por: Miyabe, Chie, et al.
Publicado: (2021)

Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness
por: Bazzi, Claudio, et al.
Publicado: (2014)

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome
por: Saito, Takao, et al.
Publicado: (2016)

The Supportive Treatment of IgA Nephropathy and Idiopathic Nephrotic Syndrome: How Useful are Omega-3 Polyunsaturated Fatty Acids?
por: Uwaezuoke, Samuel N, et al.
Publicado: (2020)

The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale
por: Mujtaba, Alhasan, et al.
Publicado: (2018)

ACE I/D Gene Polymorphism Can't Predict the Steroid Responsiveness in Asian Children with Idiopathic Nephrotic Syndrome: A Meta-Analysis
por: Zhou, Tian-Biao, et al.
Publicado: (2011)

Nephrotic-Range Proteinuria and Peripheral Edema in a Child: Not Only Idiopathic Nephrotic Syndrome
por: Dolcemascolo, Valentina, et al.
Publicado: (2016)

Unanswered questions in childhood idiopathic nephrotic syndrome
por: Lanewala, Ali, et al.
Publicado: (2013)

The glomerular permeability factors in idiopathic nephrotic syndrome
por: Davin, Jean-Claude
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qpngg8g8ipfl0a0ogi9b9tdfcg